公司概覽
業務類別 Biotechnology
業務概覽 Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
公司地址 750 W. John Carpenter Freeway, Suite 800, Irving, TX, USA, 75039
電話號碼 +1 866 771-8946
傳真號碼 --
公司網頁 https://www.carislifesciences.com
員工數量 1769
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. J. Russel Denton, M.B.A. Senior Vice President, General Counsel and Secretary -- 23/05/2025
Mr. Brian J. Brille Vice Chairman of the Board and Executive Vice President 美元 600.00K 23/05/2025
Dr. David Spetzler, M.B.A.,M.S.,PhD President 美元 600.00K 23/05/2025
Mr. Luke Power, M.B.A. Senior Vice President, Chief Financial Officer and Chief Accounting Officer -- 23/05/2025
Mr. David D. Halbert Chairman of the Board and Chief Executive Officer 美元 750.00K 23/05/2025
 
董事會成員
董事會 職務 更新日期
Dr. George H. Poste, D.V.M.,F.R.S.,PhD Vice Chairman of the Board 23/05/2025
Dr. Lloyd B. Minor, M.D. Independent Director 09/06/2025
Dr. Jeffrey L. Vacirca, F.A.C.P.,M.D. Independent Director 23/05/2025
Mr. Vijay Mohan Independent Director 23/05/2025
Mr. Brian J. Brille Vice Chairman of the Board and Executive Vice President 23/05/2025
Mr. Danny Phillips Independent Director 23/05/2025
Mr. David Fredrickson Independent Director 23/05/2025
Ms. Laura I. Johansen Independent Director 16/06/2025
Dr. Jonathan Kenneth Charles Knowles Vice Chairman of the Board 23/05/2025
Mr. Jon S. Halbert Director 23/05/2025
Mr. Joseph E. Gilliam Independent Director 23/05/2025
Mr. Nathan Burns Independent Director 23/05/2025
Mr. David D. Halbert Chairman of the Board and Chief Executive Officer 23/05/2025
Mr. Peter M. Castleman Lead Independent Director 09/06/2025
 
所屬ETF (更新日期: 07/03/2026 02:33)
代號 名稱 佔比% 持有日期
TMEDT. Rowe Price Health Care ETF0.001%28/02/2026
HELXFranklin Genomic Advancements ETF0.001%28/02/2026
VTHRVanguard Russell 3000 ETF0.001%31/01/2026
RECSColumbia Research Enhanced Core ETF0.001%04/02/2026
AVLCAvantis U.S. Large Cap Equity ETF0.0005%28/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.0004%28/02/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0004%28/02/2026
MSLCMorgan Stanley Pathway Large Cap Eq ETF0.0003%28/02/2026
TXSTexas Capital Texas Equity Index ETF0.0002%27/02/2026
FLDZRiverNorth Patriot ETF0.0002%27/02/2026
QQHGInvesco QQQ Hedged Advantage ETF0.0001%27/02/2026
GGUSGoldman Sachs MktBt Russell LgCpGrEqETF0.0001%27/02/2026
TEXNiShares Texas Equity ETF0.00003%28/02/2026
REVSColumbia Research Enhanced Value ETF0.00002%04/02/2026
BOUTInnovator IBD® Breakout Opps ETF<0.000001%06/08/2025
FDIFFidelity Disruptors ETF<0.000001%02/02/2026
GLOFiShares Global Equity Factor ETF<0.000001%19/12/2025
HQHabrdn Healthcare Investors<0.000001%31/07/2025
HQLabrdn Life Sciences Investors<0.000001%31/07/2025
NBXGNeuberger Nxt Generation Cnnctvty<0.000001%31/08/2025
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.